SEC Form 4 · accession 0001209191-15-013115
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William D. Waddill
Officer — SR. VP & CFO
Period of report
Feb 11, 2015
Accepted (ET)
Feb 12, 2015 · 8:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.40 | Feb 11, 2015 | A | 45,000 | A | — | Feb 10, 2025 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1One-fourth (1/4th) of the Option vests one year after February 11, 2015; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.